Completed OBSERVATIONAL NCT04927598

Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome

Sponsor: Assiut University

Updated 5 times since 2021 Last updated: Dec 7, 2022 Started: Oct 20, 2020 Primary completion: Oct 15, 2021 Completion: Apr 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04927598, this observational or N/A phase trial focuses on Guillain-Barre Syndrome and remains completed. Sponsored by Assiut University, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Sep 2021 — Jan 2023 [monthly]

Recruiting

First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt